Sherry Shi

500 total citations
40 papers, 304 citations indexed

About

Sherry Shi is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Sherry Shi has authored 40 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Sherry Shi's work include Acute Myeloid Leukemia Research (6 papers), Musculoskeletal synovial abnormalities and treatments (4 papers) and Microscopic Colitis (4 papers). Sherry Shi is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Musculoskeletal synovial abnormalities and treatments (4 papers) and Microscopic Colitis (4 papers). Sherry Shi collaborates with scholars based in United States, Canada and Switzerland. Sherry Shi's co-authors include Annie Guérin, Dominick Latrémouille-Viau, Raluca Ionescu‐Ittu, Rebecca Burne, George J Joseph, Eytan M. Stein, Gaetano Bonifacio, Eric Q. Wu, Derek R. Johnson and Joon H. Uhm and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sherry Shi

38 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherry Shi United States	12	79	63	58	55	48	40	304
Sheila R. Reddy United States	12	75 0.9×	30 0.5×	44 0.8×	60 1.1×	56 1.2×	32	381
Vernon F. Schabert United States	13	52 0.7×	40 0.6×	91 1.6×	58 1.1×	11 0.2×	30	461
A M M Eijsbouts Netherlands	14	47 0.6×	106 1.7×	61 1.1×	100 1.8×	14 0.3×	17	738
M R Howard United States	9	44 0.6×	33 0.5×	43 0.7×	29 0.5×	91 1.9×	12	323
Matti Rantanen Finland	10	84 1.1×	27 0.4×	99 1.7×	12 0.2×	72 1.5×	22	525
Joanne Derdak United States	12	84 1.1×	20 0.3×	71 1.2×	16 0.3×	60 1.3×	21	416
Jihyun Kwon South Korea	13	200 2.5×	63 1.0×	52 0.9×	84 1.5×	42 0.9×	51	578
Namita Joshi United States	9	24 0.3×	31 0.5×	40 0.7×	73 1.3×	29 0.6×	48	222
Anastasia Tsagianni United States	9	68 0.9×	12 0.2×	66 1.1×	43 0.8×	45 0.9×	15	325
Mutlu Karkucak Türkiye	12	37 0.5×	34 0.5×	47 0.8×	40 0.7×	39 0.8×	43	334

Countries citing papers authored by Sherry Shi

Since Specialization

Citations

This map shows the geographic impact of Sherry Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Shi more than expected).

Fields of papers citing papers by Sherry Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Shi. The network helps show where Sherry Shi may publish in the future.

Co-authorship network of co-authors of Sherry Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Shi. A scholar is included among the top collaborators of Sherry Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Shi. Sherry Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shi, Sherry, et al.. (2025). Mitigation efforts to reduce carbon dioxide emissions and meet the Paris Agreement have been offset by economic growth. Communications Earth & Environment. 6(1). 823–823. 1 indexed citations

2.

Goldschmidt, Deborah, et al.. (2024). Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran’s Affairs data. PLoS ONE. 19(12). e0315302–e0315302.

3.

Sharma, Prateek, Gary W. Falk, Menaka Bhor, et al.. (2023). Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of health economics and outcomes research. 51–58. 2 indexed citations

4.

Sharma, Prateek, Gary W. Falk, Menaka Bhor, et al.. (2023). Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States. Journal of health economics and outcomes research. 10(1). 51–58. 6 indexed citations

5.

Zagadailov, Erin, Hanny Al‐Samkari, Audra Boscoe, et al.. (2023). Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency. Hematology. 29(1). 2290746–2290746.

6.

Sharma, Prateek, Gary W. Falk, Menaka Bhor, et al.. (2023). Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States. Medicine. 102(12). e33072–e33072. 2 indexed citations

7.

Lin, Feng, Winghan Jacqueline Kwong, Sherry Shi, et al.. (2022). Author Correction: Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States. Journal of health economics and outcomes research. 9(1). 3 indexed citations

8.

Kwong, Winghan Jacqueline, et al.. (2022). Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States. Journal of health economics and outcomes research. 9(1). 68–74. 2 indexed citations

9.

Ionescu‐Ittu, Raluca, Irina Pivneva, Willy Wynant, et al.. (2021). The Economic Burden of Tenosynovial Giant Cell Tumors Among Employed Workforce in the United States. Journal of Occupational and Environmental Medicine. 63(4). e197–e202. 5 indexed citations

10.

Gauthier‐Loiselle, Marjolaine, Martin Cloutier, Anish Patel, et al.. (2021). Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis. Advances in Therapy. 38(12). 5809–5828. 13 indexed citations

11.

Willey, Cynthia, Marjolaine Gauthier‐Loiselle, Martin Cloutier, et al.. (2021). Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States. Current Medical Research and Opinion. 37(7). 1155–1162. 4 indexed citations

12.

Stein, Eytan M., Dominick Latrémouille-Viau, Sherry Shi, et al.. (2020). PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS. Value in Health. 23. S132–S133. 1 indexed citations

13.

Zagadailov, Erin, Audra Boscoe, Sherry Shi, et al.. (2020). Mortality Among Veterans with a Diagnosis of Pyruvate Kinase (PK) Deficiency: A Real-World Study Using US Veterans Health Administration Data. Blood. 136(Supplement 1). 24–25. 1 indexed citations

14.

Stein, Eytan M., Dominick Latrémouille-Viau, George J Joseph, et al.. (2019). Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis. Blood. 134(Supplement_1). 3495–3495. 7 indexed citations

15.

Guérin, Annie, Raluca Ionescu‐Ittu, Sherry Shi, et al.. (2018). Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration. European Urology Oncology. 2(1). 12–20. 15 indexed citations

16.

Borghaei, Hossein, Yeun Mi Yim, Annie Guérin, et al.. (2018). Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung Cancer. 119. 112–119. 10 indexed citations

17.

Ghate, Sameer R., Raluca Ionescu‐Ittu, Sherry Shi, et al.. (2018). Abstract 1209: Patterns of treatment with immune check point inhibitors and targeted therapy in patients with metastatic melanoma presumed BRAF V600 positive. Cancer Research. 78(13_Supplement). 1209–1209. 1 indexed citations

18.

Stein, Eytan M., Gaetano Bonifacio, Dominick Latrémouille-Viau, et al.. (2018). Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations. Journal of Medical Economics. 21(6). 556–563. 31 indexed citations

19.

Yim, Yeun Mi, A. Guérin, Raluca Ionescu‐Ittu, et al.. (2016). Impact of severe adverse events during second-line therapy on healthcare costs in patients with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 27. vi424–vi424. 1 indexed citations

20.

Winslade, Nancy, Laurel Taylor, Sherry Shi, et al.. (2011). Monitoring Community Pharmacist's Quality of Care: A feasibility study of using pharmacy claims data to assess performance. BMC Health Services Research. 11(1). 12–12. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact